BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Business

  Ablynx Regains Anti-TNF-Alpha Nanobody Rights from Pfizer Inc.

  November 4, 2011

   · 

  2 min read
• Drug Development

  Presidio Pharmaceuticals, Inc. Announces Clinical Proof-of-Concept Data for its First HCV NS5A Inhibitor, PPI-461, and Initiation of Clinical Testing for its Second-Generation NS5A Inhibitor, PPI-668

  November 4, 2011

   · 

  1 min read
• Primus Solutions Awarded Operations and Maintenance Contract at Plum Island Animal Disease Center

  November 4, 2011

   · 

  1 min read
• BioMidwest

  Researcher Sees Cancer Risk for Medtronic, Inc.'s Infuse

  November 4, 2011

   · 

  1 min read
• Business

  Cardiome Pharma Corp. Reports Third Quarter Results

  November 4, 2011

   · 

  1 min read
• Business

  Novavax, Inc. Reports Third Quarter 2011 Financial Results

  November 4, 2011

   · 

  1 min read
• Business

  Tekmira Pharmaceuticals Corporation Conference Call and Webcast Advisory: Third Quarter 2011 Operating Results and Corporate Update

  November 4, 2011

   · 

  1 min read
• Drug Development

  OXiGENE Reports Final Data From Phase 2 FALCON Study of ZYBRESTAT in Non-Small Cell Lung Cancer

  November 4, 2011

   · 

  1 min read
• Biotech Bay

  Align Technology, Inc. Executives to Present at Upcoming Financial Conferences

  November 4, 2011

   · 

  1 min read
• Business

  Novavax, Inc. Appoints Erica S. Shane, Ph.D., Vice President, Process Development

  November 4, 2011

   · 

  1 min read